Atlas Trials

Efficacy and Safety of Human Urinary Kallidinogenase for Acute Ischemic Stroke Patients Receiving Reperfusion Treatment

Clinical trial NCT06848894 · RECRUITING

Trial details

NCT number
NCT06848894
Sponsor
Beijing Tiantan Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Ischemic Stroke
Start date
2025-03-01
Primary completion
2026-12-01
Enrollment
1204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.